Measures · D05 in 2027 · Part D · DD3 Member Experience with the Drug Plan
Rating of Drug Plan
Drug PlanMember ExperienceSource: CAHPS
- What it measures
- Percent of the best possible score the plan earned from members who rated the prescription drug plan.
- How it's calculated
- This case-mix adjusted measure is used to assess members' overall view of their prescription drug plan. The Consumer Assessment of Healthcare Providers and Systems (CAHPS) score uses the mean of the responses transformed to a scale from 0 to 100. The score shown may thus be interpreted as the percentage of the best possible score each contract earned.
- Data source
- CAHPS CAHPS Survey Question (question numbers vary depending on survey type): • Using any number from 0 to 10, where 0 is the worst prescription drug plan possible and 10 is the best prescription drug plan possible, what number would you use to rate your prescription drug plan?
- Measurement period
- 03/2026 – 06/2026
- Better when
- Higher
- Weight
- 2 (Patients’ Experience and Complaints Measure)
- Star assignment
- Relative Distribution and Significance Testing
- Case-mix adjusted
- Yes
- In improvement measure
- Yes
- Used in CAI
- No
- Exclusions
Show
• Scores for contracts with fewer than 11 responses are suppressed. • Contract scores with very low interunit reliability (less than 0.60) are suppressed. More details on interunit reliability calculations can be found in Attachment K under the section titled "Relative Distribution and Significance Testing (CAHPS) Methodology".- Notes
- CAHPS Survey results were sent to each contract's Medicare Compliance Officer in August 2026. These reports provide further explanation of the CAHPS scoring methodology and provide detailed information on why a specific rating was assigned. Linear mean scoring, which takes the average of all eligible responses, is used for CAHPS measures. CAHPS measures are transformed to a 0–100 scale for public reporting using the formula Y = ((X-a)*100)/((b-a)) , where X = the CAHPS score on its original scale, ranging from a minimum value of “a” to a maximum value of “b”. Further details, as well as examples of 0–100 scale transformations for composite measures, are provided under the section header “Scoring of MA & PDP CAHPS Composite Measures” at https://www.ma-pdpcahps.org/en/scoring-and-star-ratings/.
- Disaster policy
- Higher measure star (2026-2027) for contracts with 25% or more enrolled affected by 2025 disasters.
From the 2027 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.
How the 2028 cut points are projected
Each boundary moves by its median year-on-year change since 2019. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.
| Stars | Org type | 2027 | Projected 2028 | Move |
|---|---|---|---|---|
| 2★ | MA-PD | 84 | 85 | +1 |
| 3★ | MA-PD | 86 | 86 | 0 |
| 4★ | MA-PD | 87 | 87 | 0 |
| 5★ | MA-PD | 89 | 89 | 0 |
| 2★ | PDP | 82 | 82 | 0 |
| 3★ | PDP | 83 | 83 | 0 |
| 4★ | PDP | 86 | 86 | 0 |
| 5★ | PDP | 88 | 88 | 0 |
2027 star distribution
Not rated: Plan too small to be measured (108); Plan too new to be measured (94); Plan not required to report measure (8); Not enough data available (4)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2027 | MA-PD | < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 to < 89 | >= 89 |
| 2027 | PDP | < 82 | >= 82 to < 83 | >= 83 to < 86 | >= 86 to < 88 | >= 88 |
| 2026 | MA-PD | < 85 | >= 85 to < 86 | >= 86 to < 88 | >= 88 to < 89 | >= 89 |
| 2026 | PDP | < 82 | >= 82 to < 83 | >= 83 to < 86 | >= 86 to < 88 | >= 88 |
| 2025 | MA-PD | < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 to < 89 | >= 89 |
| 2025 | PDP | < 79 | >= 79 to < 82 | >= 82 to < 85 | >= 85 to < 87 | >= 87 |
| 2024 | MA-PD | < 84 | >= 84 to < 85 | >= 85 to < 87 | >= 87 to < 89 | >= 89 |
| 2024 | PDP | < 80 | >= 80 to < 81 | >= 81 to < 83 | >= 83 to < 87 | >= 87 |
| 2023 | MA-PD | < 83 | >= 83 to < 85 | >= 85 to < 87 | >= 87 to < 88 | >= 88 |
| 2023 | PDP | < 79 | >= 79 to < 80 | >= 80 to < 83 | >= 83 to < 87 | >= 87 |
| 2022 | MA-PD | < 84 | >= 84 to < 85 | >= 85 to < 87 | >= 87 to < 88 | >= 88 |
| 2022 | PDP | < 80 | >= 80 to < 82 | >= 82 to < 84 | >= 84 to < 87 | >= 87 |
| 2021 | MA-PD | < 83 | >= 83 to < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 |
| 2021 | PDP | < 80 | >= 80 to < 81 | >= 81 to < 83 | >= 83 to < 87 | >= 87 |
| 2020 | MA-PD | < 83 | ? 83 to < 84 | ? 84 to < 86 | ? 86 to < 87 | ? 87 |
| 2020 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 83 | ? 83 to < 87 | ? 87 |
| 2019 | MA-PD | < 82 | ? 82 to < 83 | ? 83 to < 85 | ? 85 to < 87 | ? 87 |
| 2019 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 84 | ? 84 to < 86 | ? 86 |
| 2018 | MA-PD | < 81 | ? 81 to < 83 | ? 83 to < 85 | ? 85 to < 86 | ? 86 |
| 2018 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 83 | ? 83 to < 87 | ? 87 |
| 2017 | MA-PD | < 80 | ? 80 to < 82 | ? 82 to < 84 | ? 84 to < 86 | ? 86 |
| 2017 | PDP | < 79 | ? 79 to < 80 | ? 80 to < 83 | ? 83 to < 86 | ? 86 |
| 2016 | MA-PD | < 80 | ? 80 to < 82 | ? 82 to < 84 | ? 84 to < 86 | ? 86 |
| 2016 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 82 | ? 82 to < 86 | ? 86 |
| 2015 | MA-PD | < 82% | ? 82% to < 83% | ? 83% to < 84% | ? 84% to < 87% | ? 87% |
| 2015 | PDP | < 80% | ? 80% to < 81% | * | ? 81% to < 86% | ? 86% |
Lowest-scoring contracts, 2027
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| S5715 HealthSpring | Health Care Service Corporation | 197,516 | 79 | 1 | 0 | 7 | 0% |
| S5993 Horizon Blue Cross Blue Shield of New Jersey | Horizon Mutual Holdings, Inc | 35,972 | 79 | 1 | −2 | 7 | 0% |
| S5904 Florida Blue | Guidewell Mutual Holding Corporation | 46,802 | 79 | 1 | −1 | 7 | 0% |
| H1350 Blue Cross of Idaho | Gemstone Holdings, Inc. | 32,406 | 80 | 1 | −1 | 7 | 0% |
| H3418 UnitedHealthcare | UnitedHealth Group, Inc. | 46,700 | 81 | 1 | 0 | 6 | 0% |
| H1722 Healthfirst Medicare Plan | Healthfirst, Inc. | 1,924 | 81 | 1 | −2 | 6 | 0% |
| H4152 Blue Cross & Blue Shield of Rhode Island | Blue Cross & Blue Shield of Rhode Island | 74,436 | 81 | 1 | −3 | 6 | 0% |
| H1278 UnitedHealthcare | UnitedHealth Group, Inc. | 135,992 | 82 | 1 | −1 | 5 | 1% |
| H3351 Excellus Health Plan, Inc | Lifetime Healthcare, Inc. | 172,494 | 82 | 1 | −1 | 5 | 1% |
| H0029 Wellcare | Centene Corporation | 31,556 | 82 | 1 | — | 5 | 1% |
| H5587 Blue Cross Blue Shield of Arizona Health Choice | Blue Cross Blue Shield of Arizona | 8,603 | 82 | 1 | −2 | 5 | 1% |
| H5439 Wellcare | Centene Corporation | 19,153 | 82 | 1 | 0 | 5 | 1% |
| H1862 Wellcare | Centene Corporation | 12,758 | 82 | 1 | — | 5 | 1% |
| H7607 Clever Care Health Plan | Clever Care Health Plan, Inc. | 54,337 | 83 | 2 | 0 | 4 | 2% |
| H0672 HealthSpring | Health Care Service Corporation | 26,567 | 83 | 2 | 0 | 4 | 2% |
| H3335 Excellus Health Plan, Inc | Lifetime Healthcare, Inc. | 87,150 | 83 | 1 | −1 | 4 | 2% |
| H4982 Aetna Medicare | CVS Health Corporation | 9,288 | 83 | 2 | +1 | 4 | 2% |
| H6550 Wellcare | Centene Corporation | 2,010 | 83 | 1 | −2 | 4 | 2% |
| H7518 Wellcare | Centene Corporation | 3,236 | 83 | 2 | 0 | 4 | 2% |
| H9485 Mass General Brigham Health Plan | Mass General Brigham Incorporated | 18,399 | 83 | 1 | −2 | 4 | 2% |
| H9364 Wellcare | Centene Corporation | 14,819 | 83 | 1 | −1 | 4 | 2% |
| H5435 UnitedHealthcare | UnitedHealth Group, Inc. | 1,420 | 83 | 1 | −1 | 4 | 2% |
| H3864 PacificSource Medicare | PacificSource | 52,292 | 83 | 1 | −2 | 4 | 2% |
| H3447 Anthem HealthKeepers | Elevance Health, Inc. | 155,934 | 83 | 1 | −1 | 4 | 2% |
| H4544 Peoples Health | UnitedHealth Group, Inc. | 8,699 | 83 | 2 | +1 | 4 | 2% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2027 | D05 | Rating of Drug Plan | 03/2026 – 06/2026 | 2 | CAHPS |
| 2026 | D05 | Rating of Drug Plan | 03/2025 – 05/2025 | 2 | CAHPS |
| 2025 | D05 | Rating of Drug Plan | 03/2024 – 06/2024 | 4 | CAHPS |
| 2024 | D05 | Rating of Drug Plan | 03/2023 – 06/2023 | 4 | CAHPS |
| 2023 | D05 | Rating of Drug Plan | 03/2022 – 06/2022 | 4 | CAHPS |
| 2022 | D05 | Rating of Drug Plan | 03/2021 – 05/2021 | 2 | CAHPS |
| 2021 | D07 | Rating of Drug Plan | 03/2019 – 05/2019 | 2 | CAHPS |
| 2020 | D07 | Rating of Drug Plan | 03/2019 – 05/2019 | 1.5 | CAHPS |
| 2019 | D07 | Rating of Drug Plan | 03/2018 – 06/2018 | 1.5 | CAHPS |
| 2018 | D08 | Rating of Drug Plan | 03/2017 – 06/2017 | 1.5 | CAHPS |
| 2017 | D08 | Rating of Drug Plan | 02/2016 – 08/2016 | 1.5 | CAHPS |
| 2016 | D08 | Rating of Drug Plan | 02/15/2015 - 05/31/2015 | 1.5 | CAHPS |
| 2015 | D06 | Rating of Drug Plan | 02/15/2014 - 05/31/2014 | 1.5 | CAHPS |